Sight Sciences CLO sells shares for tax liability

Sight Sciences Chief Legal Officer Jeremy B. Hayden reported selling 12,733 shares of common stock, with a weighted average price of $5.51 per share.

Rhea-AI Filing Summary

Sight Sciences Chief Legal Officer Jeremy B. Hayden reported selling 12,733 shares of common stock, with a weighted average price of $5.51 per share. According to the disclosure, these shares were sold solely to cover his tax liability arising from the vesting of restricted stock units.

After this tax-related sale, Hayden holds 357,037 shares tied to Sight Sciences, including 100,015 shares of common stock and 257,022 shares that are scheduled to be received as restricted stock units vest in the future. The transaction reflects routine tax withholding rather than a discretionary reduction in his overall stake.

Insider Trade Summary 10b5-1

Net Seller: 12,733 shares

Net Sell 1 txn

Insider HAYDEN JEREMY B.

Role Chief Legal Officer

Sold 12,733 shs ($70K)

Type	Security	Shares	Price	Value
Sale	Common Stock	12,733	$5.508	$70K

Holdings After Transaction: Common Stock — 357,037 shares (Direct)

Footnotes (3)

1. F1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
2. F2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.37 to $5.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. Includes (i) 100,015 shares of Common Stock, and (ii) 257,022 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

Key Figures

Shares sold: 12,733 shares Weighted average sale price: $5.51 per share Shares after transaction: 357,037 shares +2 more

5 metrics

Shares sold 12,733 shares Common stock sold on 2026-07-06 to cover tax liability

Weighted average sale price $5.51 per share Sales executed in range $5.37–$5.62

Shares after transaction 357,037 shares Total holdings following reported sale

Current common stock held 100,015 shares Portion of post-transaction holdings in common stock

Unvested RSUs 257,022 shares Shares to be acquired upon RSU vesting and settlement

Key Terms

restricted stock units, weighted average price, vesting and settlement

3 terms

restricted stock units financial

"tax liability in connection with the vesting of restricted stock units ("RSUs")"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted average price financial

"Reflects the weighted average price at which the shares of Common Stock were sold."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

vesting and settlement financial

"shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sight Sciences (SGHT) report for Jeremy B. Hayden?

Sight Sciences reported that Chief Legal Officer Jeremy B. Hayden sold 12,733 shares of common stock. The filing states the sale was made to cover tax liabilities arising from vested restricted stock units, rather than to reduce his investment position in the company.

At what price were Jeremy B. Hayden’s SGHT shares sold in this Form 4?

The reported weighted average sale price was about $5.51 per share. Footnotes explain the shares were sold in multiple trades, with prices ranging from $5.37 to $5.62, all executed to satisfy tax obligations from RSU vesting.

How many Sight Sciences (SGHT) shares does Jeremy B. Hayden hold after this transaction?

Following the transaction, Hayden is shown with 357,037 shares tied to Sight Sciences. This includes 100,015 shares of common stock and 257,022 additional shares that will be delivered when his previously granted restricted stock units finish vesting and settling.

Was Jeremy B. Hayden’s SGHT stock sale a discretionary sale or tax-related?

The Form 4 footnotes indicate the sale was tax-related, not discretionary. The 12,733 shares were sold specifically to cover Hayden’s tax liability in connection with the vesting of restricted stock units, a common mechanism for handling equity award taxes.

What does the price range disclosed in the SGHT Form 4 indicate?

The price range shows the shares were sold in multiple trades between $5.37 and $5.62. The weighted average of these trades is reported as $5.51, and Hayden has offered to provide full trade details to the company, shareholders, or regulators upon request.

How significant is Jeremy B. Hayden’s SGHT stock sale compared to his remaining holdings?

The 12,733 shares sold represent a small portion of Hayden’s total 357,037-share position after the transaction. Because the sale was explicitly to cover taxes from RSU vesting, it appears as routine compensation-related activity rather than a major change in his ownership stake.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 07:36 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HAYDEN JEREMY B.

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/06/2026		S		12,733(1)	D	$5.508(2)	357,037(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").

2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.37 to $5.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Includes (i) 100,015 shares of Common Stock, and (ii) 257,022 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

	/s/Jeremy B. Hayden	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)